Assignee
NEW FRONTIER LABS LLC
US·5 granted patents·1 pending application·9 citations·filing 2017–2024
Top patents by PatentIndex Score
6 records- 0187US11918555B2Dicarboxylic acid esters for the treatment of diseases and conditions associated with phospholipase D toxinNEW FRONTIER LABS LLC·Filed 2021·Granted Mar 5, 2024·1 cites·12 claims
- 0287US11911358B2Dicarboxylic acid esters for inducing an analgesic effectNEW FRONTIER LABS LLC·Filed 2021·Granted Feb 27, 2024·1 cites·11 claims
- 0386US11026912B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2019·Granted Jun 8, 2021·2 cites·13 claims
- 0485US10251857B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2017·Granted Apr 9, 2019·5 cites·19 claims
- 0571US12329735B2Azelaic acid esters in the treatment of insulin resistanceNEW FRONTIER LABS LLC·Filed 2021·Granted Jun 17, 2025·0 cites·17 claims
- 0666US2026048034A1Compositions and methods for enhancing the efficacy of dicarboxylic acid esters, and uses thereofNEW FRONTIER LABS LLC·Filed 2024·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when NEW FRONTIER LABS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →